Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208645608> ?p ?o ?g. }
- W3208645608 abstract "Abstract Purpose Development of targeted biological therapies for COVID-19 requires reliable biomarkers that could help indicate the responding patients. Hyperactivation of the inflammasome by SARS-CoV2 virus is hypothesized to contribute to severe course of the COVID-19 disease. Therefore, we aimed to evaluate the prognostic value of several inflammasome-related cytokines and proteins at the admission to the intensive care unit (ICU). Patients and methods Plasma samples were obtained from 45 critically ill COVID-19 patients and from 10 patients any without any signs of infection (TBI, traumatic brain injury) on admission to the ICU. The concentration of IL-1 α , IL-1 β , IL-18, IL-1RA, galectin-1, ASC, LDH, ferritin, and gasdermin D were analyzed. A novel cell-free caspase-1 plasma assay was developed by inhibitor-based immunoprecipitation followed by Western Blot. Demographic and clinical characteristics were recorded. Results In-hospital mortality in COVID-19 patients reached 62%. Galectin-1 was 1.8-fold lower in COVID-19 than in TBI patients (17101.84 vs. 30764.20 pg/ml, p=0.007), but other inflammasome-related biomarkers were at similar concentrations. Patients with SOFA score of >9 on admission who were at high risk of death had significantly higher galectin-1 but lower IL-1RA in comparison to low-risk patients (25551.3 pg/ml vs 16302.7 pg/ml, p=0.014; 14.5 pg/ml vs 39.4 pg/ml, p=0.04, respectively). Statistically significant correlations were observed between: IL-1 α and platelets (r=-0.37), IL-1 β and platelets (r=-0.36), ferritin and INR (r=0.39). Activated caspase-1 p35 was detectable in 12/22 COVID-19 patients but in none of the TBI patients. Its presence was related with higher fibrinogen and lower D-dimers. Moreover, the densitometric analysis showed a significantly higher amount of p35 in patients with SOFA> 9. Conclusion Our results indicate that the systemic markers of activation of the inflammasome in critically ill COVID-19 patients is not directly related with outcome. Therefore, potential interventions aimed at the inflammasome pathway in this group of patients may be of limited effectiveness and should be biomarker-guided." @default.
- W3208645608 created "2021-11-08" @default.
- W3208645608 creator A5000119234 @default.
- W3208645608 creator A5012883257 @default.
- W3208645608 creator A5029445528 @default.
- W3208645608 creator A5034021575 @default.
- W3208645608 creator A5057447508 @default.
- W3208645608 creator A5071813305 @default.
- W3208645608 creator A5086868436 @default.
- W3208645608 date "2021-11-01" @default.
- W3208645608 modified "2023-10-15" @default.
- W3208645608 title "Inflammasome-related markers at the ICU admission are not associated with outcome in the critically ill COVID-19 patients" @default.
- W3208645608 cites W1997033640 @default.
- W3208645608 cites W2617626520 @default.
- W3208645608 cites W2907328820 @default.
- W3208645608 cites W2952125019 @default.
- W3208645608 cites W2982045176 @default.
- W3208645608 cites W3012116029 @default.
- W3208645608 cites W3027333181 @default.
- W3208645608 cites W3031736683 @default.
- W3208645608 cites W3034095150 @default.
- W3208645608 cites W3041667892 @default.
- W3208645608 cites W3044132961 @default.
- W3208645608 cites W3082201689 @default.
- W3208645608 cites W3087139986 @default.
- W3208645608 cites W3088792741 @default.
- W3208645608 cites W3092938204 @default.
- W3208645608 cites W3110882068 @default.
- W3208645608 cites W3119685153 @default.
- W3208645608 cites W3125797720 @default.
- W3208645608 cites W3133550736 @default.
- W3208645608 cites W3133604326 @default.
- W3208645608 cites W3134550228 @default.
- W3208645608 cites W3135791721 @default.
- W3208645608 cites W3145052564 @default.
- W3208645608 cites W3162905796 @default.
- W3208645608 cites W3163576071 @default.
- W3208645608 cites W3199081300 @default.
- W3208645608 cites W3202535722 @default.
- W3208645608 doi "https://doi.org/10.1101/2021.10.30.21265662" @default.
- W3208645608 hasPublicationYear "2021" @default.
- W3208645608 type Work @default.
- W3208645608 sameAs 3208645608 @default.
- W3208645608 citedByCount "1" @default.
- W3208645608 countsByYear W32086456082022 @default.
- W3208645608 crossrefType "posted-content" @default.
- W3208645608 hasAuthorship W3208645608A5000119234 @default.
- W3208645608 hasAuthorship W3208645608A5012883257 @default.
- W3208645608 hasAuthorship W3208645608A5029445528 @default.
- W3208645608 hasAuthorship W3208645608A5034021575 @default.
- W3208645608 hasAuthorship W3208645608A5057447508 @default.
- W3208645608 hasAuthorship W3208645608A5071813305 @default.
- W3208645608 hasAuthorship W3208645608A5086868436 @default.
- W3208645608 hasBestOaLocation W32086456081 @default.
- W3208645608 hasConcept C11988809 @default.
- W3208645608 hasConcept C126322002 @default.
- W3208645608 hasConcept C177713679 @default.
- W3208645608 hasConcept C2776376669 @default.
- W3208645608 hasConcept C2776914184 @default.
- W3208645608 hasConcept C2777209026 @default.
- W3208645608 hasConcept C2779134260 @default.
- W3208645608 hasConcept C2781197716 @default.
- W3208645608 hasConcept C2987404301 @default.
- W3208645608 hasConcept C2991859549 @default.
- W3208645608 hasConcept C3008058167 @default.
- W3208645608 hasConcept C524204448 @default.
- W3208645608 hasConcept C55493867 @default.
- W3208645608 hasConcept C71924100 @default.
- W3208645608 hasConcept C86803240 @default.
- W3208645608 hasConcept C90924648 @default.
- W3208645608 hasConceptScore W3208645608C11988809 @default.
- W3208645608 hasConceptScore W3208645608C126322002 @default.
- W3208645608 hasConceptScore W3208645608C177713679 @default.
- W3208645608 hasConceptScore W3208645608C2776376669 @default.
- W3208645608 hasConceptScore W3208645608C2776914184 @default.
- W3208645608 hasConceptScore W3208645608C2777209026 @default.
- W3208645608 hasConceptScore W3208645608C2779134260 @default.
- W3208645608 hasConceptScore W3208645608C2781197716 @default.
- W3208645608 hasConceptScore W3208645608C2987404301 @default.
- W3208645608 hasConceptScore W3208645608C2991859549 @default.
- W3208645608 hasConceptScore W3208645608C3008058167 @default.
- W3208645608 hasConceptScore W3208645608C524204448 @default.
- W3208645608 hasConceptScore W3208645608C55493867 @default.
- W3208645608 hasConceptScore W3208645608C71924100 @default.
- W3208645608 hasConceptScore W3208645608C86803240 @default.
- W3208645608 hasConceptScore W3208645608C90924648 @default.
- W3208645608 hasLocation W32086456081 @default.
- W3208645608 hasOpenAccess W3208645608 @default.
- W3208645608 hasPrimaryLocation W32086456081 @default.
- W3208645608 hasRelatedWork W1984498786 @default.
- W3208645608 hasRelatedWork W2000329364 @default.
- W3208645608 hasRelatedWork W2057630253 @default.
- W3208645608 hasRelatedWork W2274076556 @default.
- W3208645608 hasRelatedWork W2280614645 @default.
- W3208645608 hasRelatedWork W2327606279 @default.
- W3208645608 hasRelatedWork W2331454882 @default.
- W3208645608 hasRelatedWork W2362037864 @default.
- W3208645608 hasRelatedWork W2474790959 @default.
- W3208645608 hasRelatedWork W2753993308 @default.
- W3208645608 isParatext "false" @default.